Zenith Health Care
3.12
-0.01(-0.32%)
Market Cap₹16.75 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D-0.32%
1M+0.97%
6M-8.77%
1Y-22.39%
5Y-61.34%
View Company Insightsright
More news about Zenith Health Care
11Apr 26
Zenith Healthcare Limited Submits RTA Declaration for Quarter Ended March 31, 2026
Zenith Healthcare Limited filed its quarterly RTA declaration under Regulation 74(5) of Depositories and Participants Regulations 2018 for Q4 FY26 ended March 31, 2026. The company submitted the mandatory compliance document to BSE on April 11, 2026, along with a certificate from Bigshare Services Private Limited confirming proper handling of dematerialization processes and compliance with regulatory requirements.
 no imag found
12Feb 26
Zenith Healthcare Reports Strong Q3FY26 Turnaround with ₹22.41 Lakh Net Profit
Zenith Healthcare Limited reported a strong financial turnaround in Q3FY26 with net profit of ₹22.41 lakh compared to a loss of ₹29.22 lakh in Q3FY25. Revenue from operations increased to ₹248.30 lakh, while the nine-month period showed net profit of ₹34.71 lakh against previous year's loss of ₹4.27 lakh. The company demonstrated improved operational efficiency with reduced material costs and positive earnings per share of ₹0.042.
 no imag found
11Nov 25
Zenith Healthcare Reports Mixed Q2 Results with Revenue Dip, Profit Growth for H1 FY2026
Zenith Healthcare Limited released its Q2 FY2026 results, showing a 9.6% quarter-on-quarter decline in revenue to ₹302.79 crore and a 9.5% drop in net profit to ₹21.88 crore. However, half-yearly results were more positive, with H1 FY2026 revenue increasing 14% year-over-year to ₹638.58 crore and net profit surging 70.9% to ₹39.34 crore. The company's balance sheet remains strong with total equity of ₹752.92 lakh against total assets of ₹1,072.03 lakh. The Board approved these results on November 11, 2025.
 no imag found
Zenith Health Care
3.12
-0.01
(-0.32%)
1 Year Returns:-22.39%
Industry Peers
Sun Pharmaceutical
1,957.50
(-0.31%)
Divis Laboratories
8,350.50
(-2.73%)
Torrent Pharmaceuticals
5,016.50
(-0.66%)
Cipla
1,450.70
(-1.61%)
Zydus Life Science
1,117.60
(-0.30%)
Lupin
2,388.00
(-0.21%)
Mankind Pharma
2,451.60
(-1.26%)
Laurus Labs
1,834.30
(+1.26%)
Dr Reddys Laboratories
1,160.10
(-1.69%)
Aurobindo Pharma
1,568.20
(+0.87%)